Drug Interactions between finerenone and landiolol
This report displays the potential drug interactions for the following 2 drugs:
- finerenone
- landiolol
Interactions between your drugs
landiolol finerenone
Applies to: landiolol and finerenone
Consumer information for this interaction is not currently available.
MONITOR: Concomitant use of multiple other antihypertensive agents or drugs with hypotensive properties may potentiate the risk of hypotension during treatment with finerenone. In a phase 3 clinical study, hypotension was reported in 4.8% of patients treated with finerenone compared to 3.4% of patients receiving placebo. The majority of hypotension events in the finerenone group were mild or moderate and resolved. Finerenone treatment was permanently discontinued due to hypotension in one patient (<0.1%), while hospitalization due to hypotension was 0.2% in both the finerenone group and the placebo group. Mean systolic blood pressure decreased by 2 to 4 mmHg and mean diastolic blood pressure decreased by 1 to 2 mmHg with finerenone treatment at one month, but remained stable thereafter.
MANAGEMENT: Blood pressure should be monitored regularly in patients receiving finerenone with other antihypertensive agents. Patients should be advised to contact their physician if they experience symptoms of hypotension such as dizziness, lightheadedness, or fainting.
Drug and food interactions
finerenone food
Applies to: finerenone
Finerenone may be taken with or without food. However, you should avoid grapefruit and grapefruit juice during treatment with this medication. Grapefruit juice may significantly increase the blood levels and effects of finerenone. This can increase the risk of developing hyperkalemia, or high levels of potassium in the blood, which in severe cases can lead to kidney failure, muscle paralysis, irregular heart rhythm, and cardiac arrest. You may be more likely to develop hyperkalemia during treatment with finerenone if you are elderly, dehydrated, or have kidney disease, diabetes, or advanced heart failure. You should also avoid potassium-containing salt substitutes or over-the-counter potassium supplements during treatment with finerenone unless otherwise directed by your doctor. Seek medical attention if you experience nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat, as these may be symptoms of hyperkalemia. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
See also
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.